How Do Antineoplastic Pan-Deacetylase Inhibitors Work

Reviewed on 10/25/2021

HOW DO ANTINEOPLASTIC PAN-DEACETYLASE INHIBITORS WORK?

Antineoplastic pan-deacetylase inhibitors are a class of drugs used to treat patients with multiple myeloma (a type of cancer of the bone marrow) who have received at least two prior regimens, including bortezomib and an immunomodulatory agent.

The only drug that belongs to this class is “Panobinostat” which is an antineoplastic medication and acts as a nonselective histone deacetylase (an enzyme) inhibitor. Blocking this enzyme induces apoptosis (a genetically regulated form of cell death) of malignant (cancerous) cells.

Pan-deacetylase inhibitors are administered orally with or without food, typically once every other day for three doses per week in Weeks 1 and 2 of each 21-day cycle for up to eight cycles. 

Pan-deacetylase inhibitors work in the following ways:

  • They are chemotherapy medications that work by slowing or stopping the growth of cancer cells.
  • They work by inhibiting an enzyme “histone deacetylase” promoting apoptosis of malignant cells.

HOW ARE ANTINEOPLASTIC PAN-DEACETYLASE INHIBITORS USED?

Antineoplastic pan-deacetylase inhibitors are indicated in combination with bortezomib and dexamethasone for multiple myeloma in patients who have received at least two prior regimens, including bortezomib and an immunomodulatory agent.

WHAT ARE SIDE EFFECTS OF ANTINEOPLASTIC PAN-DEACETYLASE INHIBITORS?

Some of the common side effects include:

Other rare side effects include:

Information contained herein is not intended to cover all possible side effects, precautions, warnings, drug interactions, allergic reactions, or adverse effects. Check with your doctor or pharmacist to make sure these drugs do not cause any harm when you take them along with other medicines. Never stop taking your medication and never change your dose or frequency without consulting your doctor.

SLIDESHOW

Understanding Cancer: Metastasis, Stages of Cancer, and More See Slideshow

WHAT ARE NAMES OF ANTINEOPLASTIC PAN-DEACETYLASE INHIBITORS?

Generic and brand names of antineoplastic pan-deacetylase inhibitors include:

References
https://reference.medscape.com/drugs/antineoplastics-pan-deacetylase-inhibitors

https://www.webmd.com/drugs/2/drug-167899/panobinostat-oral/details

https://www.cancer.gov/news-events/cancer-currents-blog/2015/fda-approves-panobinostat

https://www.rxlist.com/farydak-drug.htm#side_effects

https://medlineplus.gov/druginfo/meds/a615020.html

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5315073/

Health Solutions From Our Sponsors